Attralus, Inc.
Attralus, Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| 124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome | Amyloid Neuropathies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cumulative Trauma Disorders, Nutritional and Metabolic Diseases, Sprains and Strains, amyloidosis, bone disorder, carpal tunnel syndrome, familial amyloid neuropathy, hereditary amyloidosis, hereditary disease, inborn errors of metabolism, inherited neurodegenerative disorder, injury, lumbar spinal stenosis, median nerve neuropathy, metabolic disease, mononeuropathy, musculoskeletal system disorder, nerve compression syndrome, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, proteostasis deficiencies, spinal stenosis, vertebral column disorder | Enrolling by invitation | Phase 2 | 2026-07-21 | NCT06907849 | |
| A Study of AT-02 in Subjects With Systemic Amyloidosis. | Immunoglobulin Light-chain Amyloidosis, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, amyloidosis, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, metabolic disease, monoclonal gammopathy, neoplasm, plasma cell neoplasm, proteostasis deficiencies | Active, not recruiting | Phase 2 | 2026-05-06 | NCT05951049 | |
| Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis | Nutritional and Metabolic Diseases, amyloidosis, familial amyloid neuropathy, metabolic disease, proteostasis deficiencies | Recruiting | Phase 2 | 2026-04-13 | NCT05758493 |